In a new study, researchers from Queen Mary College, University of London, UK, discovered that molecules released from invasive skin cancer reprogram the healthy immune cells to help spread cancer. Targeting these molecules with inhibitory drugs may help prevent this invasive skin cancer from recurring after treatment. The results of the study were published in the Cell, entitled “Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via…